Semmelweis University; 1st Department of Pediatrics, Pediatric Nephrology Center
About Semmelweis University; 1st Department of Pediatrics, Pediatric Nephrology Center
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Semmelweis University; 1st Department of Pediatrics, Pediatric Nephrology Center
During the past decade, Semmelweis University; 1st Department of Pediatrics, Pediatric Nephrology Center conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 2 clinical trials were completed, i.e. on
average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or Naproxen
2006-10-04
2016-04-12
Completed
24,081
A Study of the Effectiveness and Safety of Ramipril in the Treatment of Hypertension in Children and Adolescents
2006-10-01
2007-11-01
Terminated
422
Coronary Artery Bypass Surgery (CABG) Off or On Pump Revascularization Study
2007-10-01
2016-09-01
Completed
4,752
Endurant Stent Graft Natural Selection Global Postmarket Registry
2009-04-08
2021-09-23
Completed
1,266
Safety and Clinical Performance of the Protecta ICD and CRT-D
2009-09-01
2013-09-01
Completed
2,770
Selexipag (ACT-293987) in Pulmonary Arterial Hypertension
2009-12-01
2014-10-01
Completed
1,156
A Study of Rituximab (MabThera) Subcutaneous (SC) Versus Rituximab (MabThera) Intravenous in Participannts With Follicular Non-Hodgkin's Lymphoma
2011-02-15
2017-10-31
Completed
410
A Study of Obinutuzumab in Combination With CHOP Chemotherapy Versus Rituximab With CHOP in Participants With CD20-Positive Diffuse Large B-Cell Lymphoma (GOYA)
2011-07-26
2018-01-31
Terminated
1,418
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Semmelweis University; 1st Department of Pediatrics, Pediatric Nephrology Center
According to Clinical.Site data, the most researched conditions in "Semmelweis University; 1st Department of Pediatrics, Pediatric Nephrology Center" are
"Anemia" (1 trials), "Renal Anemia" (1 trials) and "Renal Insufficiency, Chronic" (1 trials). Many other conditions were trialed in "Semmelweis University; 1st Department of Pediatrics, Pediatric Nephrology Center" in a lesser frequency.
Clinical Trials Intervention Types at Semmelweis University; 1st Department of Pediatrics, Pediatric Nephrology Center
Most popular intervention types in "Semmelweis University; 1st Department of Pediatrics, Pediatric Nephrology Center" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "Methoxy Polyethylene Glycol-Epoetin Beta" (1 trials) and "Mircera" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Semmelweis University; 1st Department of Pediatrics, Pediatric Nephrology Center
The vast majority of trials in "Semmelweis University; 1st Department of Pediatrics, Pediatric Nephrology Center" are
2 trials for "All" genders.
Clinical Trials Status at Semmelweis University; 1st Department of Pediatrics, Pediatric Nephrology Center
Currently, there are NaN active trials in "Semmelweis University; 1st Department of Pediatrics, Pediatric Nephrology Center".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Semmelweis University; 1st Department of Pediatrics, Pediatric Nephrology Center,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Semmelweis University; 1st Department of Pediatrics, Pediatric Nephrology Center, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".